| 【Company Research】InnoCare Pharma (9969 HK) – Breakup with Biogen on orelabrutinib for the treatment of autoimmune diseases |
| 【Company Research】Pinduoduo (PDD US) – Resilient GMV growth to sustain in 2023 |
| 【Company Research】Xiabu Xiabu Catering (520 HK) – Much needed reforms to bring XBXB nationwide |
| 【Company Research】AK Medical (1789 HK) – Accelerating import substitution; positive outlook of 2023E |
| 【Company Research】Yancoal Australia (3668 HK) – Confirmation of price cap and volume to remove overhang |
| 【Fixed Income Research】HK corps: Perps offer better value than seniors |
| 【Sector Research】China Property Sector – Good news is bad news? |
| 【Company Research】JOYY Inc. (YY US) – Looking beyond 1Q23E soft seasonality |
| 【Sector Research】China Auto Sector – Inventory risk could lead to a bumpy recovery |
| 【Company Research】Xiaomi (1810 HK) – 2023 Investor Day: All eyes on profitability and smart EV business upside |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
